Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Amrta Karuna Syrup: Dosage Form: syrup
Dose: 15 ml
Frequency: 2 times daily after meal
Route of administration: oral
Duration of therapy: 14 days
Control Intervention1: Standard trea
Sponsors
Vopec Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects age group 18 - 65 years both gender 2.Patients diagnosed with COVID-19 positive mild symptomatic patients (Confirmed by RTPCR) - Patients with uncomplicated upper respiratory infection a. Spo2 >94% in room air b. Respiratory rate c. No evidence of hypoxaemia or breathlessness 3. Subjects willing to give a written informed consent and come for a regular follow up 4. Subject willing to abide by and comply with the study protocol
Exclusion criteria
Exclusion criteria: i.Presence of acute hypoxic respiratory failure. ii.Intensive care unit (ICU) stay. iii. Patients who need mechanical ventilation. iv.Category 6 or 5 based on modified 7-category ordinal scale of clinical status
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Evaluate The Safety And Efficacy Of Amrta Karuna syrup In mildly symptomatic COVID- 19 patients Timepoint: Day 0 to 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.LDH, TLC, CRP, D-DIMER and RT PCR from baseline to end of the study i.e. 14 days. 2.RT PCR test will do Day 0,Day 7 and Day 10 Timepoint: Day 0,Day 7,Day 10 and Day 14 | — |
Countries
India
Contacts
Public ContactDrDinesh
Vopec Pharmaceuticals (P) Ltd
Outcome results
None listed